Growth PotentialHeartflow is poised to deliver above-average growth and margin performance with a projected 24% growth CAGR from 2025 to 2028.
Market PositioningHeartflow is favorably positioned for continued share gains in both the coronary blood flow and plaque analysis markets.
Technological AdvancementHeartflow's AI-based products are set to change the standard of care in the detection of coronary artery disease, benefiting from a highly differentiated diagnostic solution in a large, untapped market.